The impact of COVID-19 on heart failure admissions in Suriname-A call for action

S Sairras1, S Baldew2, C Goberdhan2

  • 1Scientific Research Center Suriname (SRCS), Academic Hospital Paramaribo (AZP), Suriname.

Insights

Heart failure (HF) admissions decreased during the COVID-19 pandemic, but readmissions rose significantly. Implementing telehealth strategies in Suriname can improve healthcare access and mitigate adverse effects for HF patients.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • The COVID-19 pandemic prompted global healthcare reorganizations, impacting services for chronic conditions like heart failure (HF).
  • Limited data exists on the pandemic's effect on HF hospitalizations in Low and Middle Income Countries (LMICs), such as Suriname.

Purpose of the Study:

  • To assess changes in heart failure hospitalizations in Suriname before and during the COVID-19 pandemic.
  • To identify the need for improved healthcare access through telehealth strategies in LMICs.

Main Methods:

  • Retrospective analysis of clinical and demographic data for patients hospitalized with HF at Academic Hospital Paramaribo.
  • Comparison of data from February-December 2019 (pre-pandemic) and February-December 2020 (during the pandemic).
  • Statistical analysis using t-tests for continuous variables and two-sample proportion tests for categorical variables.

Main Results:

  • A 9.1% decrease in overall HF admissions was observed during the pandemic.
  • Significantly fewer patients were hospitalized (18.3% decrease), but readmissions increased significantly (90-day: 19.6% vs 13.2%; 365-day: 31.9% vs 16.7%).
  • Pandemic admissions showed significantly higher rates of comorbidities: hypertension (46.2%), diabetes (31.9%), anemia (12.8%), and atrial fibrillation (22.7%).

Conclusions:

  • The COVID-19 pandemic led to reduced HF admissions but increased readmissions in Suriname.
  • The inactivity of the HF clinic due to consultation restrictions highlights the need for remote monitoring solutions.
  • Developing and implementing telehealth strategies, addressing digital literacy and legislation, is crucial for improving HF care in LMICs.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
29
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
28
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
18
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
19
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
647